News | CT Angiography (CTA) | May 26, 2016

First U.S. Toshiba Infinix 4-D CT Installed at Arkansas Cancer Center

Combination CT/angiography system offers true CT imaging prior, during and after interventional procedures

Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center

May 26, 2016 — Cancer patients at the Carti Cancer Center, Little Rock, Ark., now have access to the latest innovation in diagnostic imaging with Toshiba America Medical Systems Inc.’s Infinix 4-D CT. Carti is the first healthcare provider in the United States to install the Infinix 4-D CT, which merges the Infinix-i angiography system and Aquilion One Vision Edition computed tomography (CT) system. The combination is designed to help clinicians improve visualization and work flow, and increase patient safety.

Carti is utilizing the system for interventional radiology and oncology to plan, treat and verify in a single clinical setting. Real CT imaging available on demand may help interventionalists improve visualization of tumors and feeder vessels, as well as provide whole organ body perfusion, to help them not only plan and treat but also verify their procedures. For example, during hepatoma embolizations, interventionalists can immediately visualize and confirm that treatment is hitting the right areas with CT and identify feeder vessels, enabling the interventionalists to guide catheters into the vessels with the angiography system’s 3-D roadmap.

Carti is also using the system during liver ablations and kyphoplasty procedures, among other applications.

“Interventional radiology and oncology is born from innovation, and technology advancements like the Infinix 4-D CT create exciting new possibilities and prepare us for the future of care,” said David Hays, M.D., director, diagnostic and interventional radiology, Carti. “For today’s patients, the system makes procedures that were difficult to perform and turns them into manageable cases that are easier, faster and more accurate.”

The Infinix-i enables clinicians to provide precision and flexibility during intervention with fingertip-to-fingertip and head-to-toe coverage, and enables easier patient access with the Access Halo. The Aquilion One Vision Edition is capable of capturing an entire organ in one rotation with 640 slices with coneXact double slice reconstruction and 16 cm of true anatomical coverage. This produces image quality that far exceeds CT-like imaging of the interventional lab. The combination of the interventional lab and CT eliminates the need to transfer patients between departments and allows clinicians to decrease procedure time and maintain patient safety.

Toshiba’s third-generation iterative dose reconstruction software, AIDR 3-D (Adaptive Iterative Dose Reduction 3-D), offers simplified CT dose reduction, while the Infinix has a suite of dose management features including the Dose Tracking System.

For more information: www.medical.toshiba.com

Related Content

Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging mod
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
ControlRad Announces FDA Clearance and Launch of ControlRad Trace
Technology | Radiation Dose Management | May 23, 2019
ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res